Partner With Us NRI

Decipher Labs Ltd share Price Today

Company details

6M Return 0.33%
1Y Return -46.24%
Mkt Cap.(Cr) 18.35
Volume 37,219
Div Yield 0.00%
OI Chg %
Volume 37,219

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Decipher Labs Ltd Stocks COMPARISION


Equity Capital: 23.21 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,819.21 39,849.27
LAST 3M 59,182.99 17,912.96
LAST 6M 101,166.54 92,564.27
LAST 12M 166,925.45 138,096.90

Decipher Labs Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Decipher Labs Ltd. (formerly known as Combat Drugs Ltd) was incorporated as a Private Limited Company in September, 1986 and was converted into a Public Limited Company in Jun.`92. The company was promoted by Suchit Mohan Lal and Ajay Karan. The Company is a professionally managed, well established, diversified Public Limited Company, engaged in the Manufacture & Marketing of Pharmaceuticals and allied products and services and providing Services and key Solutions in Information Technology Industry. Since inception, the Company has been manufacturing & marketing its branded formulations and custom manufacturing for various companies besides supplies of various Bulk drugs, chemicals and Finished Formulations. During the years of operations, it has garnered a reputation as a quality provider in the Pharmaceutical industry and the Products marketed by the Company have been well accepted by the Trade and Medical Fraternity across India.? The Company also diversified interest in the field on Information Technology and has developed a name for itself as a key solution provider in the field of associated technologies. It expanded by reviving the Information Technology wing and started dealing and reviving its associations into the Information Technology Industry. To increase presence in the Information Technology segment, the Company acquired Decipher Software Solutions LLC in USA to add good volumes to the overall turnover and Profits of the Company. The Company came out with a public issue of 23.23 lac equity shares at par aggregating Rs 2.32 cr in Nov.`94. The proceeds of the issue were utilised to part-finance a Rs 3.25-cr project to expand the existing manufacturing facilities for pharmaceutical formulations and to diversify into the manufacture of sterile powder injectables. CDL started commercial production in Jul.`87 on a loan-licence basis. The company acquired a full-fledged manufacturing unit located at Balanagar, Hyderabad, on lease from Fairchild Laboratories and commenced commercial production in Aug.`88. In Jul.`92 the manufacturing activities were shifted to the present leased premises at Kushaiguda, Hyderabad. In this unit various pharmaceutical formulations such as tablets, capsules and liquids are being manufactured. The product range of CDL comprises vital anti-bacterial drugs, antibiotic drugs, anti-inflammatory drugs, haematenic drugs and protein tonic. CDL has developed in-house technology for the manufacture of dispersible and sustained release formulations. The company is exploring the possibilities of exporting its products to Nigeria and West Indies. During the year 1995-96, the expansion programme undertaken by the company was successfully completed and the unit at Yellampet has become operational. During 1996-97, the company has expanded its operations to new areas. It has expanded its product range by introduction of Liquid Orals. The product "HB 2" has been well accepted in the market. The company has also filled its application for obtaining the (c)GMP and WHO GMP Certificate.

Registered Address

4th Flr Plot-94 Sagar Society, Banjara Hills Road No 2, Hyderabad, Telangana, 500034

Email : info:combatdrugs.in
Website : http://www.combatdrugs.in

Venture Capital & Corp. Inv.

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 100
BSE Code : 524752
NSE Code :
Book Closure Date (Month) :
BSE Group : X
ISIN : INE643N01012

FAQ’s on Decipher Labs Ltd Shares

You can buy Decipher Labs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Decipher Labs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Dec 08, 2023 04:01 PM the closing price of Decipher Labs Ltd was ₹ 18.17.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Dec 08, 2023 04:01 PM, the market cap of Decipher Labs Ltd stood at ₹ 18.35.

The latest PE ratio of Decipher Labs Ltd as of Dec 08, 2023 04:01 PM is 0

The latest PB ratio of Decipher Labs Ltd as of Dec 08, 2023 04:01 PM is 1.12

The 52-week high of Decipher Labs Ltd is ₹ 35.40 while the 52-week low is ₹ 12.00

Download Our App

market app
market app